Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Maternal serum perlecan levels in women with preeclampsia.

Hypertension in pregnancy - 1 Feb 2020

Akbas Murat, Koyuncu Faik Mumtaz, Artunc-Ulkumen Burcu, Taneli Fatma, Ozdemir Habib

Abstract excerpt

Objective: Perlecan is an extracellular matrix proteoglycan suggested to maintain endothelial functions. We aimed to measure maternal serum perlecan levels in different preeclampsia phenotypes.Methods: This study included 50 women with preeclampsia and 30 healthy pregnant women.Results: Serum perlecan levels were significantly higher (p = 0.016) in preeclamptic women with severe features(n = 23) than preeclampsia...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Case-Control Studies
Share to Cross-Sectional Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heparan Sulfate Proteoglycans

Share to Phenotype

Share to Pre-Eclampsia

Share to Pregnancy

Share to Severity of Illness Index

Source

Identifiers

PMID: 31899995
DOI: 10.1080/10641955.2019.1711390

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Maternal serum perlecan levels in women with preeclampsia.PMID 31899995Read ↗

Glycosylated fibronectin as a biomarker for preeclampsia and preeclampsia-related complicationsSemantic proximity Read ↗

Comprehensive Maternal Serum Proteomic Profiles of Preclinical and Clinical PreeclampsiaSemantic proximity Read ↗

Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsiaSemantic proximity Read ↗

Novel interactions of perlecan: Unraveling perlecan's role in angiogenesisSemantic proximity Read ↗

Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsiaSemantic proximity Read ↗

Fetal human leukocyte antigen-C and maternal killer-cell immunoglobulin-like receptors in cases of severe preeclampsiaSemantic proximity Read ↗

Lower circulating angiotensin II levels are related to the severity of preeclampsia and its risk as disclosed by a specific bioassaySemantic proximity Read ↗

Comparative N-Glycoproteomic and Phosphoproteomic Profiling of Human Placental Plasma Membrane between Normal and Preeclampsia Pregnancies with High-Resolution Mass SpectrometrySemantic proximity Read ↗

Assessment of relationships between novel inflammatory markers and presence and severity of preeclampsia: Epicardial fat thickness, pentraxin-3, and neutrophil-to-lymphocyte ratioSemantic proximity Read ↗

An altered pattern of circulating apolipoprotein E3 isoforms is implicated in preeclampsiaSemantic proximity Read ↗

Extracellular matrix components in preeclampsiaSemantic proximity Read ↗

Long-term alterations in maternal plasma proteome after sFlt1–induced preeclampsia in miceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.